See for further details and safety information
Get in touch with us today to schedule your appointment!
Given the pre-existing data on GLP-1 and glucagon, we designed a double-blinded randomised cross-over study, in which we gave volunteers who were overweight short-term intravenous infusions of glucagon (50 ng/kg/min or 14 pmol/kg/min), GLP-1 (0.8 pmol/kg/min), combination of glucagon + GLP-1 at the same doses, or placebo over 45 minutes, and demonstrated that there was a significant increase in resting energy expenditure with glucagon alone which was preserved with the combination of glucagon + GLP-1, whereas GLP-1 did not affect energy expenditure (66)
In addition to monotherapy, aspirin-loaded nanoparticles can be used in combination with other anticancer agents, such as chemotherapeutic drugs, to create synergistic treatment strategies
Connect with a healthcare provider who can help you explore whether GLP-1 medications might be part of your personalized approach to health and wellness